Molecular imaging of cancer metabolism in vivo is increasingly employed in clinical settings. Both 18F-FDG PET and hyperpolarized [1-13C]pyruvate MRSI are sensitive to glucose metabolism but differ in which part of the glycolytic pathway is probed. We hypothesize that hyperPET may improve cancer specific metabolic phenotyping. Simultaneous 18F-FDG PET and hyperpolarized [1-13C]pyruvate MRSI (hyperPET) was used in a pilot study, examining the metabolic characteristics exhibited by four different cancer cell lines in nude mice. The results indicated that the combined modalities may distinguish between cancer types.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords